SG
ABMD

Stonnington Group’s Abiomed Inc ABMD Stock Holding History

Stonnington Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,300
Closed -$582K – 220
2022
Q3 		$582K Buy
2,300
+700
+44% +$189K 0.16% 117
2022
Q2 		$428K Buy
+1,600
New +$432K 0.11% 148
2022
Q1 		– Sell
-2,600
Closed -$830K – 275
2021
Q4 		$830K Buy
2,600
+200
+8% +$67.6K 0.18% 122
2021
Q3 		$809K Buy
2,400
+100
+4% +$33.9K 0.18% 128
2021
Q2 		$748K Buy
+2,300
New +$706K 0.17% 139

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Stonnington Group's ABMD Position: Q4 2022 in Review

Stonnington Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,300 shares — an estimated $582K sold.

Stonnington Group first reported a position in ABMD in Q2 2021 and held it in 5 quarters. The position peaked at $830K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Stonnington Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Stonnington Group sold 2,300 Abiomed Inc shares in Q4 2022, an estimated $582K.
  • Stonnington Group first reported a position in Abiomed Inc in Q2 2021 and held it in 5 quarters.
  • Stonnington Group's Abiomed Inc position peaked at $830K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Stonnington Group's 13F filing for Q4 2022, filed 11 Jan 2023.